CVS Health Corporation (CVS) Business News

Track CVS Health Corporation in real time with a live news feed covering CVS Health Corporation stock news, official press releases, company announcements, and an archive of historical CVS Health Corporation news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
6:46 PM | Tuesday | Mar 31, 2026 Zacks Investment Research

CVS Health (CVS) Increases Yet Falls Behind Market: What Investors Need to Know

News Thumbnail
9:56 AM | Tuesday | Mar 31, 2026 Zacks Investment Research

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

News Thumbnail
3:32 AM | Tuesday | Mar 31, 2026 Defense World

apricus wealth LLC Lowers Position in CVS Health Corporation $CVS

News Thumbnail
9:56 AM | Tuesday | Mar 31, 2026 Zacks Investment Research

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

News Thumbnail
3:32 AM | Tuesday | Mar 31, 2026 Defense World

apricus wealth LLC Lowers Position in CVS Health Corporation $CVS

News Thumbnail
12:00 PM | Monday | Mar 30, 2026 PRNewsWire

CVS Pharmacy® celebrates opening of first pharmacy-only location in Chicago

News Thumbnail
4:35 AM | Sunday | Mar 29, 2026 Defense World

Canoe Financial LP Buys 194,555 Shares of CVS Health Corporation $CVS

News Thumbnail
4:45 AM | Thursday | Mar 26, 2026 Defense World

Czech National Bank Buys 12,600 Shares of CVS Health Corporation $CVS

News Thumbnail
10:00 AM | Wednesday | Mar 25, 2026 Seeking Alpha

CVS Health's Discounted Buying Opportunity Is Here - Robust Fundamentals And Secure Dividends

News Thumbnail
12:41 PM | Tuesday | Mar 24, 2026 Reuters

CVS reaches insulin pricing settlement with FTC

News Thumbnail
10:31 AM | Tuesday | Mar 24, 2026 Zacks Investment Research

Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?

News Thumbnail
7:15 AM | Friday | Mar 20, 2026 The Motley Fool

Best Healthcare Stocks to Buy After the Market Pullback

News Thumbnail
2:44 AM | Friday | Mar 20, 2026 Defense World

CVS Health Corporation (NYSE:CVS) Receives Average Rating of “Moderate Buy” from Brokerages

News Thumbnail

CVS Health (CVS) Increases Yet Falls Behind Market: What Investors Need to Know

Zacks Investment Research

6:46 PM | Tuesday | Mar 31, 2026

news photo
Loading...

CVS Health (CVS) closed at $71.82 in the latest trading session, marking a +2.4% move from the prior day.

Read full article redirect
6:46 PM | Tuesday | Mar 31, 2026

CVS Health (CVS) Increases Yet Falls Behind Market: What Investors Need to Know

Zacks Investment Research

CVS Health (CVS) closed at $71.82 in the latest trading session, marking a +2.4% move from the prior day.

Read full article arrow
News Thumbnail
9:56 AM | Tuesday | Mar 31, 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks Investment Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Read full article arrow
News Thumbnail
3:32 AM | Tuesday | Mar 31, 2026

apricus wealth LLC Lowers Position in CVS Health Corporation $CVS

Defense World

apricus wealth LLC lowered its stake in shares of CVS Health Corporation (NYSE: CVS) by 90.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,135 shares of the pharmacy operator's stock after selling 39,325 shares during the period. apricus

Read full article arrow
News Thumbnail
9:56 AM | Tuesday | Mar 31, 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks Investment Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Read full article arrow
News Thumbnail
3:32 AM | Tuesday | Mar 31, 2026

apricus wealth LLC Lowers Position in CVS Health Corporation $CVS

Defense World

apricus wealth LLC lowered its stake in shares of CVS Health Corporation (NYSE: CVS) by 90.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,135 shares of the pharmacy operator's stock after selling 39,325 shares during the period. apricus

Read full article arrow
News Thumbnail
12:00 PM | Monday | Mar 30, 2026

CVS Pharmacy® celebrates opening of first pharmacy-only location in Chicago

PRNewsWire

Small, dedicated neighborhood pharmacies to open in select communities to help increase access to convenient pharmacy care Openings are part of ongoing commitment to serve communities and meet consumers where they are  WOONSOCKET, R.I., March 30, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today unveiled the first of nearly 20 pharmacy-only, apothecary-style CVS Pharmacy® locations it plans to open this year to increase access to pharmacy care.

Read full article arrow
News Thumbnail
4:35 AM | Sunday | Mar 29, 2026

Canoe Financial LP Buys 194,555 Shares of CVS Health Corporation $CVS

Defense World

Canoe Financial LP lifted its stake in shares of CVS Health Corporation (NYSE: CVS) by 11.4% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,899,163 shares of the pharmacy operator's stock after acquiring an additional 194,555 shares during the

Read full article arrow
News Thumbnail
4:45 AM | Thursday | Mar 26, 2026

Czech National Bank Buys 12,600 Shares of CVS Health Corporation $CVS

Defense World

Czech National Bank increased its stake in shares of CVS Health Corporation (NYSE: CVS) by 3.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 334,729 shares of the pharmacy operator's stock after purchasing an additional 12,600 shares during the quarter.

Read full article arrow
News Thumbnail
10:00 AM | Wednesday | Mar 25, 2026

CVS Health's Discounted Buying Opportunity Is Here - Robust Fundamentals And Secure Dividends

Seeking Alpha

Proposed flat reimbursement rates for Medicare Advantage pressure recovery prospects, with CVS likely to suffer enrollment declines from the higher premiums through FY2027. Despite so, their diversified healthcare segments are likely to support their sustainable operations, aided by the potentially healthier membership base at higher rates. Thanks to the industry-wide pessimism, CVS is now undervalued at FWD P/E of 9.97x and 3Y PEG of 0.85x, with it triggering a bull-case PT of $83.
60.

Read full article arrow
News Thumbnail
12:41 PM | Tuesday | Mar 24, 2026

CVS reaches insulin pricing settlement with FTC

Reuters

CVS ​Health said ‌on ​Tuesday ​it has ⁠reached ​a ​proposed settlement ​agreement ​with the Federal ‌Trade ⁠Commission on ​insulin ​pricing.

Read full article arrow
News Thumbnail
10:31 AM | Tuesday | Mar 24, 2026

Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?

Zacks Investment Research

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Read full article arrow
News Thumbnail
7:15 AM | Friday | Mar 20, 2026

Best Healthcare Stocks to Buy After the Market Pullback

The Motley Fool

CVS Health's diversified business can help it overcome recent challenges. AbbVie's two most important medicines are performing extremely well.

Read full article arrow
News Thumbnail
2:44 AM | Friday | Mar 20, 2026

CVS Health Corporation (NYSE:CVS) Receives Average Rating of “Moderate Buy” from Brokerages

Defense World

CVS Health Corporation (NYSE: CVS - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty-three analysts that are covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and twenty have given a buy rating to the company. The average 12 month target

Read full article arrow
News Thumbnail